Related Experiment Videos
Hemochromatosis: diagnosis and management
1Wright State University School of Medicine, Dayton, Ohio, USA.
Insights
Hemochromatosis is an inherited iron overload disorder damaging organs like the liver and heart. Early diagnosis through iron studies and treatment with phlebotomy can prevent severe complications.
Area of Science:
- Genetics and Metabolism
- Gastroenterology and Hepatology
- Cardiology
Background:
- Hemochromatosis is a common autosomal recessive disorder affecting iron metabolism.
- It leads to progressive organ damage, particularly in the liver, pancreas, and heart.
- The condition is more prevalent in males and individuals of white ethnicity.
Observation:
- Clinical presentation is often nonspecific, necessitating a high index of suspicion.
- Abnormal iron studies, including elevated serum ferritin and transferrin saturation, suggest the diagnosis.
- Symptoms may include diabetes mellitus, hepatic dysfunction, and congestive heart failure.
Findings:
- Liver biopsy can confirm hemochromatosis and assess for cirrhosis.
- Magnetic resonance imaging (MRI) may reveal characteristic iron deposition.
- A diagnostic response to phlebotomy, indicated by a rapidly normalizing hematocrit, supports the diagnosis.
Implications:
- Phlebotomy effectively reduces total body iron, preventing further organ damage.
- Timely treatment mitigates premature morbidity and mortality associated with hemochromatosis.
- Screening in affected families is recommended, with broader population screening under evaluation.
Abstract:
Hemochromatosis is a disorder of iron metabolism that causes progressive damage to the liver, pancreas, heart and other organs. It is the most common autosomal recessive disorder among whites, and it occurs five times more frequently in males than in females. Manifestations include diabetes mellitus, hepatic dysfunction, congestive heart failure and other end-organ insufficiency. The presentation of hemochromatosis is often nonspecific, requiring the clinician to maintain a high index of suspicion. The diagnosis is suggested by abnormal iron studies, most notably an elevated serum ferritin level and/or transferrin saturation. Liver biopsy can confirm the diagnosis and document the presence of cirrhosis. The diagnosis is also supported by characteristic findings on a magnetic resonance imaging scan, and a diagnostic response to repeated phlebotomy (a hematocrit level that rapidly returns to normal). Phlebotomy treatments reduce the total body iron load, prevent continuing deposition of iron in the tissues, and prevent premature morbidity and mortality. Screening is recommended in affected families, and screening programs for wider populations are being evaluated.